Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey.
Fiche publication
Date publication
décembre 2016
Journal
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VELTEN Michel
Tous les auteurs :
Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M,
Lien Pubmed
Résumé
Healthcare cost savings are closely linked to prescribers' confidence in and acceptance of the prescription of biosimilar drugs.
Mots clés
Adult, Aged, Antirheumatic Agents, therapeutic use, Biosimilar Pharmaceuticals, therapeutic use, Drug Prescriptions, statistics & numerical data, Female, France, Health Care Surveys, Humans, Internet, Male, Middle Aged, Pilot Projects, Practice Patterns, Physicians', statistics & numerical data, Rheumatologists, statistics & numerical data
Référence
BioDrugs. 2016 Dec;30(6):585-592